Biovaxys Technology Corp (TSE:BIOV) has released an update.
BioVaxys Technology Corp. has received a management cease trade order due to a delay in filing its annual financial reports, attributed to additional audit requirements and the acquisition of assets from IMV Inc. This order, which restricts trading by certain company executives but not by the general public, was sought by the company as an alternative to a full trading suspension. BioVaxys is actively working to resolve these issues and expects to file the required financial statements within 30 days of the missed deadline.
For further insights into TSE:BIOV stock, check out TipRanks’ Stock Analysis page.
